1. Home
  2. IRIX vs BLAC Comparison

IRIX vs BLAC Comparison

Compare IRIX & BLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • BLAC
  • Stock Information
  • Founded
  • IRIX 1989
  • BLAC 2020
  • Country
  • IRIX United States
  • BLAC United States
  • Employees
  • IRIX N/A
  • BLAC N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BLAC
  • Sector
  • IRIX Health Care
  • BLAC
  • Exchange
  • IRIX Nasdaq
  • BLAC NYSE
  • Market Cap
  • IRIX 27.5M
  • BLAC 26.3M
  • IPO Year
  • IRIX 1996
  • BLAC 2023
  • Fundamental
  • Price
  • IRIX $1.51
  • BLAC N/A
  • Analyst Decision
  • IRIX Hold
  • BLAC
  • Analyst Count
  • IRIX 1
  • BLAC 0
  • Target Price
  • IRIX $2.00
  • BLAC N/A
  • AVG Volume (30 Days)
  • IRIX 30.8K
  • BLAC 32.0K
  • Earning Date
  • IRIX 03-25-2025
  • BLAC 01-01-0001
  • Dividend Yield
  • IRIX N/A
  • BLAC N/A
  • EPS Growth
  • IRIX N/A
  • BLAC N/A
  • EPS
  • IRIX N/A
  • BLAC N/A
  • Revenue
  • IRIX $48,431,000.00
  • BLAC N/A
  • Revenue This Year
  • IRIX N/A
  • BLAC N/A
  • Revenue Next Year
  • IRIX $5.44
  • BLAC N/A
  • P/E Ratio
  • IRIX N/A
  • BLAC N/A
  • Revenue Growth
  • IRIX N/A
  • BLAC N/A
  • 52 Week Low
  • IRIX $1.27
  • BLAC $3.01
  • 52 Week High
  • IRIX $3.65
  • BLAC $13.40
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 38.42
  • BLAC 9.80
  • Support Level
  • IRIX $1.46
  • BLAC $5.61
  • Resistance Level
  • IRIX $1.60
  • BLAC $7.18
  • Average True Range (ATR)
  • IRIX 0.05
  • BLAC 0.72
  • MACD
  • IRIX -0.01
  • BLAC -1.22
  • Stochastic Oscillator
  • IRIX 18.75
  • BLAC 0.00

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About BLAC BELLEVUE LIFE SCIENCES ACQ CORP

Bellevue Life Sciences Acquisition Corp is a blank check company.

Share on Social Networks: